View all newsletters
Receive our newsletter - data, insights and analysis delivered to you

Economic Update: UNCTAD projects trade decline of 27% – IMF questions future financial stability – UK Jobseekers exceed 2 million

By Paul Dennis

19 May

The coronavirus pandemic has led to a 3% drop in global trade values in the first quarter of 2020, according to the United Nations Conference on Trade and Development.

The downturn is expected to accelerate in the second quarter, according to UNCTAD forecasts, which project a quarter-on-quarter decline of 27%.

International Monetary Fund researchers have written in a blog that relying on monetary policy alone to respond to shocks from events such as Covid-19 might not be enough and also raise questions about side effects on future financial stability and threats to central bank independence:

“While keeping an eye on debt sustainability concerns over the long term, fiscal policy needs to play a larger role. Putting in place more automatic fiscal responses in advanced economies could help build their resilience to future adverse shocks.

“If rules for fiscal stimulus are well communicated and established before shocks occur, they can help shape expectations and reduce uncertainty, thereby dampening the drop in activity once a negative shock materialises.”

The UK Office for National Statistics said that in April there was a 69.1% month-on-month increase in the number of claims for Jobseeker’s Allowance, taking the level to over 2 million.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Clinical Trials Arena